Meclizine

DRUG6 trials

Sponsors

Lehigh Valley Hospital, Duke University, Apsen Farmaceutica S.A., Vanderbilt University, Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Conditions

Benign Paroxysmal Positional VertigoHealthyHealthy VolunteersPostoperative Nausea and VomitingSmoking CessationVertigo, Peripheral

Phase 1

The Effects of Antihistamines on Pre-Pulse Inhibition

CompletedNCT01537471

Duke UniversityHealthy

Start: 2012-01-31End: 2012-09-30Updated: 2013-01-16

Phase 2

Meclizine as a Potential Smoking Cessation Treatment

CompletedNCT01443858

Duke UniversitySmoking Cessation

Start: 2011-08-31End: 2013-07-31Updated: 2014-08-01

Phase 3

Non Inferiority of Meclin® (Meclizine Chlorhydrate) Versus Dramin® (Dimenhydrinate) in Control of Acute Vertigo Symptoms From Peripheral Origin

CompletedNCT02112578

Apsen Farmaceutica S.A.Vertigo, Peripheral

Start: 2016-11-01End: 2017-12-01Updated: 2023-02-08

Phase 4

Study to Assess Safety and Tolerability of KarXT With Administration of Antiemetics in Healthy Volunteers

Not yet recruitingNCT07681076

Karuna Therapeutics, Inc., a Bristol Myers Squibb companyHealthy Volunteers

Start: 2026-08-03End: 2026-11-30Target: 225Updated: 2026-07-02

Unknown Phase

Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients

CompletedNCT00641797

Lehigh Valley HospitalBenign Paroxysmal Positional Vertigo

Start: 2006-11-30End: 2013-11-30Updated: 2018-04-03

Real-time Decision Support for Postoperative Nausea and Vomiting (PONV) Prophylaxis

CompletedNCT02625181

Vanderbilt UniversityPostoperative Nausea and Vomiting

Start: 2016-07-31End: 2017-11-30Updated: 2019-03-07